LATEST ALERTS
CBD-Intel business news in brief, 3rd-9th August 2019
13th August 2019 - News analysis |
The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel’s weekly News In Brief.
Policy and Politics
CBD-Intel bonus midweek regulatory alerts, 8th August 2019
8th August 2019 - News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe
CBD-Intel regulatory news in brief
5th August 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa
Epidyolex takes huge step toward EU licensing
31st July 2019 - News analysis |
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
Senate hearing raises hope of SAFE banking for US CBD industry
25th July 2019 - News analysis |
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
FDA gathers in opposing strong views and cannabis-related anecdotes
25th July 2019 - News analysis |
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
CBD-Intel regulatory news in brief
24th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
CBD-Intel regulatory news in brief
22nd July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
US senators push for law change to ease research into CBD and cannabis
18th July 2019 - News analysis |
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Congressional pressure builds in favour of progress on CBD
17th July 2019 - News analysis |
Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon
It’s business as unusual over CBD in topsy-turvy Washington circles
15th July 2019 - News analysis |
CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise
CBD-Intel regulatory news in brief
15th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam
Call for UK authority to regulate and trial cannabis-based medicines
11th July 2019 - News analysis |
The UK Centre for Medical Cannabis (CMC) has called for a Cannabinoid Clinical Trials Authority to regulate and test cannabis-based medicinal products
CBD-Intel regulatory news in brief
11th July 2019 - Alerts , News analysis , Regulatory alerts roundup |
An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa
Get-tough German authorities accused of ‘witch-hunt’ against CBD companies
9th July 2019 - Regulatory reports |
A German CBD company claims it can’t sell 90% of its stock following action by local authorities, while others are said to be facing charges of involvement in the illegal drug trade
UK health committee says more research will lead to greater trust
4th July 2019 - News analysis |
A group of British MPs is recommending that more trials and research are carried out into cannabis-based medical products (CBMPs), including those containing CBD
Health Canada opens consultation on prescription-free CBD health products
4th July 2019 - News analysis |
The Canadian government has taken a first step towards allowing health products containing CBD – and potentially other cannabinoids – without a prescription
How bigger firms can help smaller rivals stay afloat in a rising market
3rd July 2019 - News analysis |
Smaller CBD stakeholders should not fear the entrance of big business into the market, according to one expert who explains how larger firms can help ease the regulatory path
CBD-Intel regulatory news in brief, 17th-21st June
24th June 2019 - Alerts , News analysis , Regulatory alerts roundup |
A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from around the US, Belgium, France, Latvia, and Colombia
Industrial hemp regulations loom: Jilin province regulatory report
19th June 2019 - Regulatory reports |
As regulations in China continue to evolve, we look at developments in the third Chinese province to consider new regulations for industrialised hemp
South Africa legalises lower doses of CBD – but only for a trial year
18th June 2019 - News analysis |
A landmark decision by South Africa’s now former health minister Aaron Motsoledi has legalised lower dosage CBD. But there’s a catch – the ruling only applies until May 2020
French stores re-open, with advice to keep it legal despite uncertainties
18th June 2019 - News analysis |
The number of French CBD shops reopening after facing legal action continues to rise, with at least seven shopkeepers acquitted of charges against them
Canada regulatory report: major updates
13th June 2019 - Regulatory reports |
Canada is the centre for the world’s largest cannabis companies and has recently implemented a wide-ranging new regulatory environment for all cannabis products
CBD enjoys a predominantly good press from the British national papers
12th June 2019 - News analysis |
British national newspapers have run nearly 300 articles related to CBD over the last year – and the lion’s share have been overwhelmingly positive
Tilray denies failing to provide samples for UK clinical trials
7th June 2019 - News analysis |
International cannabis company Tilray has denied an accusation by the British Paediatric Neurological Association that it failed to provide sample products for testing
FDA’s big meeting leaves long road ahead shrouded in uncertainty
6th June 2019 - News analysis |
A meeting between the US FDA and members of the CBD industry provided the agency with plenty of information, but threw little light on the path it is likely to take
Florida regulatory snapshot
4th June 2019 - Regulatory reports |
As part of our ongoing series of concise reports on how CBD is regulated across the US, we look at Florida – where a new law is on the way
Is the NFL about to relax its stance on CBD?
4th June 2019 - News analysis |
CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American football.
CBD business news in brief: worldwide, 27-31st May
3rd June 2019 - News analysis |
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Bank associations pressure US Congress for cannabis banking reform
29th May 2019 - News analysis |
Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform
CBD business news in brief: worldwide, 20-24th May 2019
27th May 2019 - News analysis |
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
What will European Parliament elections mean for CBD?
23rd May 2019 - News analysis |
Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation
CBD and cannabis news in brief: International
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station
CBD and cannabis news in brief: Europe
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU
Tennessee brings ‘smoking hemp’ into its legal lexicon
17th May 2019 - News analysis |
The Tennessee legislature has enacted a bill which defines “smoking hemp”
Government funding puts wind in the sails of Irish CBD companies
16th May 2019 - News analysis |
Funding is available for Irish CBD businesses from Enterprise Ireland, a government body facilitating business development
Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat
16th May 2019 - News analysis |
The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry
Legal CBD firms face cash chaos as US Bank cancels their card accounts
14th May 2019 - News analysis |
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal
New Zealand’s recreational cannabis referendum won’t affect CBD
9th May 2019 - News analysis |
A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD
US veterans at odds with federal agency over legalising clinical trials
8th May 2019 - News analysis |
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis
CBD is a feminist issue too as women take a progressive leading role
1st May 2019 - News analysis |
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment
Hemp growing on the rise, but Ireland still sends abroad for medical supplies
25th April 2019 - News analysis |
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP
24th April 2019 - News analysis |
A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families
Mexican legalisation may come with added regulation and controls
18th April 2019 - News analysis |
Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime
Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’
17th April 2019 - News analysis |
Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
US attorney general favours bid to let states decide cannabis and CBD policy
16th April 2019 - News analysis |
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies
Questions in UK parliament after medical cannabis is seized at airport
9th April 2019 - News analysis |
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
US Postal Service offers guidance on mail delivery of CBD products
4th April 2019 - News analysis |
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue
Ohio Senate passes bill to establish CBD market, as Texas delists hemp
3rd April 2019 - News analysis |
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances
UK government loses a pro-cannabis minister as Brine exits over Brexit
3rd April 2019 - News analysis |
UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues
